AU2002348501A1 - Factor xa inhibitor - Google Patents

Factor xa inhibitor

Info

Publication number
AU2002348501A1
AU2002348501A1 AU2002348501A AU2002348501A AU2002348501A1 AU 2002348501 A1 AU2002348501 A1 AU 2002348501A1 AU 2002348501 A AU2002348501 A AU 2002348501A AU 2002348501 A AU2002348501 A AU 2002348501A AU 2002348501 A1 AU2002348501 A1 AU 2002348501A1
Authority
AU
Australia
Prior art keywords
inhibitor
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002348501A
Other languages
English (en)
Inventor
Benjamin Alan Diseroad
Gary Lowell Engel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2001/002553 external-priority patent/WO2001096323A1/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2002348501A1 publication Critical patent/AU2002348501A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2002348501A 2001-06-12 2002-06-06 Factor xa inhibitor Abandoned AU2002348501A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PCT/GB2001/002553 WO2001096323A1 (en) 2000-06-13 2001-06-12 Serine protease inhibitors
AUPCT/GB2001/002553 2001-06-12
US33929501P 2001-12-12 2001-12-12
US60/339,295 2001-12-12
PCT/US2002/016569 WO2002100847A2 (en) 2001-06-12 2002-06-06 Factor xa inhibitor

Publications (1)

Publication Number Publication Date
AU2002348501A1 true AU2002348501A1 (en) 2002-12-23

Family

ID=41210812

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002348501A Abandoned AU2002348501A1 (en) 2001-06-12 2002-06-06 Factor xa inhibitor

Country Status (13)

Country Link
US (1) US20040162295A1 (enExample)
EP (1) EP1397348B1 (enExample)
JP (1) JP2004534062A (enExample)
AR (1) AR036048A1 (enExample)
AT (1) ATE305452T1 (enExample)
AU (1) AU2002348501A1 (enExample)
DE (1) DE60206376T2 (enExample)
ES (1) ES2248618T3 (enExample)
MY (1) MY137876A (enExample)
PE (1) PE20030198A1 (enExample)
SV (1) SV2003001085A (enExample)
TW (1) TWI257389B (enExample)
WO (1) WO2002100847A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE384713T1 (de) * 2001-07-26 2008-02-15 Lilly Co Eli 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazine und -piperidine als faktor-xa-antagonisten
IL164018A0 (en) 2002-04-01 2005-12-18 Lilly Co Eli Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa
EA010307B1 (ru) * 2004-06-30 2008-08-29 Эли Лилли Энд Компани Фармацевтическое соединение
KR100849242B1 (ko) * 2004-06-30 2008-07-29 일라이 릴리 앤드 캄파니 1(인돌-6-카르보닐-ｄ-페닐글리시닐)-4-(1-메틸피페리딘-4-일) 피페라진 ｄ-타르트레이트
DE102007028407A1 (de) 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
DE102007028406A1 (de) 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
DE102007028319A1 (de) 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
EP2875020B1 (en) * 2012-07-19 2017-09-06 Boehringer Ingelheim International GmbH Process for the preparation of a fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy- chinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1192132B1 (en) * 1999-06-14 2005-09-07 Eli Lilly And Company Serine protease inhibitors
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds

Also Published As

Publication number Publication date
EP1397348A2 (en) 2004-03-17
PE20030198A1 (es) 2003-03-12
SV2003001085A (es) 2003-03-18
ATE305452T1 (de) 2005-10-15
WO2002100847A3 (en) 2003-08-21
MY137876A (en) 2009-03-31
EP1397348B1 (en) 2005-09-28
TWI257389B (en) 2006-07-01
US20040162295A1 (en) 2004-08-19
DE60206376D1 (de) 2006-02-09
DE60206376T2 (de) 2006-06-22
JP2004534062A (ja) 2004-11-11
ES2248618T3 (es) 2006-03-16
WO2002100847A2 (en) 2002-12-19
AR036048A1 (es) 2004-08-04

Similar Documents

Publication Publication Date Title
AU2002351179A1 (en) Glycinamides as factor xa inhibitors
AU2001273040A1 (en) Factor xa inhibitors
HRP20040453A2 (en) Indole-2-carboxamides as factor xa inhibitors
AU2002359163A1 (en) New use
AU2002365896A1 (en) SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS
IL162454A0 (en) Pyrrolidine-2-ones as factor xa inhibitors
AU2002300754A1 (en) New Combination
AUPR878201A0 (en) New compounds
AUPR362001A0 (en) New compound
AU2002349621A1 (en) Angiogenesis inhibitor
AU2002359464A1 (en) Angiopioetin related factors
AU2002348501A1 (en) Factor xa inhibitor
AU2003296393A1 (en) Factor xa inhibitors
AU2002222933A1 (en) Inhibitors of factor xa
AU2002360673A1 (en) Gp41 inhibitor
AU2002325882A1 (en) Phenyl derivatives as factor Xa inhibitors
AU2002358811A1 (en) Plasterboard
AU2001283340A1 (en) Factor viia inhibitors
AUPR957401A0 (en) Panels
WO2003031574A3 (en) Elastase inhibitors
HK1069393A (en) Pyrrolidine-2-ones as factor xa inhibitors
AU2001100406A4 (en) DriverSMS
AU2002332238A1 (en) Entry inhibitor
AU2001100338A4 (en) Sunglove
AU2001100214A4 (en) Dolly-trolley

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase